Cargando…

Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor

BACKGROUND: Intravenous immunoglobulin (IVIg) has been used to treat a variety of autoimmune disorders including multiple sclerosis (MS); however its mechanism of action remains elusive. Recent work has shown that interleukin-11 (IL-11) mRNAs are upregulated by IVIg in MS patient T cells. Both IVIg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figueiredo, Carlyn A., Drohomyrecky, Paulina C., McCarthy, Stephen D. S., Leontyev, Danila, Ma, Xue-Zhong, Branch, Donald R., Dunn, Shannon E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117465/ https://www.ncbi.nlm.nih.gov/pubmed/25078447 http://dx.doi.org/10.1371/journal.pone.0101947

Ejemplares similares

Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
Publicado: (2014)

Peroxisome Proliferator-Activated Receptor-δ Deficiency in Microglia Results in Exacerbated Axonal Injury and Tissue Loss in Experimental Autoimmune Encephalomyelitis
por: Doroshenko, Ellinore R., et al.
Publicado: (2021)

Combined Treatment with Zinc Aspartate and Intravenous Immunoglobulins (IVIGs) Ameliorates Experimental Autoimmune Encephalomyelitis (EAE)
por: Straubel, Diana, et al.
Publicado: (2018)

Interleukin-19 Abrogates Experimental Autoimmune Encephalomyelitis by Attenuating Antigen-Presenting Cell Activation
por: Horiuchi, Hiroshi, et al.
Publicado: (2021)

Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
por: Connery, Kathleen, et al.
Publicado: (2018)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Intravenous Immunoglobulins at the Crossroad of Autoimmunity and Viral Infections
por: Perricone, Carlo, et al.
Publicado: (2021)

The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis
por: Lee, Soon‐Tae, et al.
Publicado: (2022)

Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12
Publicado: (1995)

Transgenic Interleukin 10 Prevents Induction of Experimental Autoimmune Encephalomyelitis
por: Cua, Daniel J., et al.
Publicado: (1999)

R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
por: Schmitz, Katja, et al.
Publicado: (2014)

Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats
por: Yan, Jun, et al.
Publicado: (2016)

Emodin attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis
por: Cui, Yue-Ran, et al.
Publicado: (2022)

High-Dose Intravenous Immunoglobulin in Skin Autoimmune Disease
por: Hoffmann, Jochen H. O., et al.
Publicado: (2019)

Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020)

Intravenous Immunoglobulins as Immunomodulators in Autoimmune Diseases and Reproductive Medicine
por: Velikova, Tsvetelina, et al.
Publicado: (2023)

Conventional Housing Conditions Attenuate the Development of Experimental Autoimmune Encephalomyelitis
por: Arndt, Andreas, et al.
Publicado: (2014)

Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis
por: Hsiao, Yai-Ping, et al.
Publicado: (2020)

Neutralization of Interleukin-9 Decreasing Mast Cells Infiltration in Experimental Autoimmune Encephalomyelitis
por: Yin, Jun-Jie, et al.
Publicado: (2017)

596 Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria
por: Alyoshkin, Vladimir
Publicado: (2012)

Intravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory Dermatoses
por: Dourmishev, Lyubomir A., et al.
Publicado: (2016)

Greatly attenuated experimental autoimmune encephalomyelitis in aquaporin-4 knockout mice
por: Li, Lihua, et al.
Publicado: (2009)

Lactobacillus helveticus SBT2171 Attenuates Experimental Autoimmune Encephalomyelitis in Mice
por: Yamashita, Maya, et al.
Publicado: (2018)

Crotalphine Attenuates Pain and Neuroinflammation Induced by Experimental Autoimmune Encephalomyelitis in Mice
por: Giardini, Aline C., et al.
Publicado: (2021)

Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
por: Ruiz, Florian, et al.
Publicado: (2023)

Local Delivery of Interleukin 4 by Retrovirus-Transduced T Lymphocytes Ameliorates Experimental Autoimmune Encephalomyelitis
por: Shaw, Michael K., et al.
Publicado: (1997)

Suppression of experimental autoimmune encephalomyelitis by interleukin-10 transduced neural stem/progenitor cells
por: Klose, Juliane, et al.
Publicado: (2013)

Use of intravenous immunoglobulin for the treatment of autoimmune encephalitis: audit of the NHS experience
por: Kinsella, JA, et al.
Publicado: (2018)

Severe statin-induced autoimmune myopathy successfully treated with intravenous immunoglobulin
por: Güngör, Cansu, et al.
Publicado: (2020)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice
por: Ma, Xiaomeng, et al.
Publicado: (2010)

Tuftsin Promotes an Anti-Inflammatory Switch and Attenuates Symptoms in Experimental Autoimmune Encephalomyelitis
por: Wu, Muzhou, et al.
Publicado: (2012)

Celastrol Attenuates Multiple Sclerosis and Optic Neuritis in an Experimental Autoimmune Encephalomyelitis Model
por: Yang, Hongbin, et al.
Publicado: (2017)

Gliosis attenuation in experimental autoimmune encephalomyelitis by a combination of dimethyl fumarate and pregabalin
por: Hoelz, Amanda Garcia, et al.
Publicado: (2022)

Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin–associated hemolysis
por: Cen, Selena Y., et al.
Publicado: (2019)

Efficacy of Synthetic Peptide Corresponding to the ACTH-Like Sequence of Human Immunoglobulin G1 in Experimental Autoimmune Encephalomyelitis
por: Turobov, Valery I., et al.
Publicado: (2018)

Teriflunomide Attenuates Immunopathological Changes in the Dark Agouti Rat Model of Experimental Autoimmune Encephalomyelitis
por: Ringheim, Garth E., et al.
Publicado: (2013)

Rifampicin attenuates experimental autoimmune encephalomyelitis by inhibiting pathogenic Th17 cells responses
por: Ma, Ke, et al.
Publicado: (2016)

Lactobacillus acidipiscis Induced Regulatory Gamma Delta T Cells and Attenuated Experimental Autoimmune Encephalomyelitis
por: Ren, Saisai, et al.
Publicado: (2021)

High-intensity interval training attenuates development of autoimmune encephalomyelitis solely by systemic immunomodulation
por: Goldberg, Yehuda, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2haq1jlpr67luihl1h4758p6dq